PainReform Ltd.

As of April 28, 2025, the market trend is mildly bearish due to daily moving averages and bearish signals from KST and Dow Theory, although weekly and monthly MACD show mild bullishness, indicating mixed signals and a cautious outlook.

PainReform Ltd. is an Israeli pharmaceutical company specializing in the reformulation of existing pain medications, classified as a micro-cap with a market cap of USD 3.46 million and a recent net profit of -7 million.

As of Jun 18, PainReform Ltd. has a market capitalization of 3.46 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a consolidated net profit of -17.67 million over the latest four quarters.